Cargando...
Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway
Dramatic advances in immune therapy have emerged as a promising strategy in cancer therapeutics. In addition to chemotherapy and radiotherapy, inhibitors targeting immune-checkpoint molecules such as cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed cell death receptor-1 (PD-1) and its ligand (P...
Guardado en:
| Publicado en: | J Biomed Sci |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894306/ https://ncbi.nlm.nih.gov/pubmed/31801525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-019-0588-8 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|